Tumor SPARC Microenvironment Signature and Plasma Levels in a Phase II Trial of Unresectable Stage IV Melanoma Treated With nab-Paclitaxel and Carboplatin: A Translational Study of NCCTG Trial N057E
- Citation:
- J Clin Oncol vol 28 (15s) abstr 8578
- Meeting Instance:
- ASCO 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 265
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Experimental
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- S. Markovic V. Suman V. Treiu X. Liu W. Yeh L. Hwang T. Treece K. Motamed P. Pramanik N. Desai
- Networks:
- Study
- NCCTG-N057E
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: